Post by Champions Oncology, Inc.

11,968 followers

Missed the live webinar? You can now watch it on demand. πŸŽ₯ In this webinar hosted by Drug Discovery World, Michael R. and Alex Moreau, PhD explore how patient-derived models are helping uncover the mechanisms behind sensitivity and resistance to pan‑RAS(ON) inhibition. Drawing on data from 50+ KRAS-mutant PDX models, the discussion highlights the impact of genomic context, co-mutations, and prior treatment history on therapeutic response, providing valuable insights for researchers advancing KRAS-targeted therapies. Watch on demand and discover how clinically relevant patient-derived models can support more informed drug development strategies. πŸ”— Watch now: https://hubs.li/Q04nW2fd0 #KRAS #DrugDiscovery #CancerResearch #PrecisionOncology #PDXModels #OncologyResearch #TranslationalResearch #ChampionsOncology

Post content

Video Content